The state of Nebraska currently has 1 active clinical trials seeking participants for Hepatitis B research studies. These trials are conducted in various cities, including Omaha, Lincoln, Kearney and Grand Island.
Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection
Recruiting
The goals of this clinical study are to compare the effectiveness, safety and tolerability of study drug, tenofovir alafenamide (TAF), versus placebo in teens and children with CHB and to learn more about the dosing levels in children.
Gender:
All
Ages:
Between 2 years and 17 years
Trial Updated:
02/23/2024
Locations: Children's Hospital & Medical Center, Omaha, Nebraska
Conditions: Chronic Hepatitis B